Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
WYNDHAM HOTELS & RESORTS, INC.
WH
Other
Share Repurchase Activity Disclosed
Quarterly Dividend Declared
Effective Tax Rate Reconciliation
Adjusted Ebitda Period Comparison
Weighted Average Interest Rate Disclosed
Restructuring Charge Disclosed
Interest Rate Swap Disclosed
Net Loss Reported
International Expansion
Pricing Pressure
Rsu Psu Vesting Schedule Disclosed
Stock Option Grant Disclosed
Cash Flow Statement Investing Activities
Workforce Reduction Restructuring Plan
Business Services
Demand Softening
Other
Share Repurchase Activity Disclosed
Adjusted Ebitda Period Comparison
Quarterly Dividend Declared
Earnings Call Replay Details
Leverage Ratio Disclosure
International Expansion
Market Share Gaining
Ceo Earnings Call Commentary
Pricing Pressure
Free Cash Flow Metric Disclosed
Weighted Average Interest Rate Disclosed
Business Services
Demand Softening
Healthcare
Utilization Declining Services
Pricing Power Services
SaaS
Bookings Deceleration
Other
Share Repurchase Activity Disclosed
Quarterly Dividend Declared
Effective Tax Rate Reconciliation
Adjusted Ebitda Period Comparison
Weighted Average Interest Rate Disclosed
Restructuring Charge Disclosed
Financing Activities Cash Flow Disclosure
Interest Rate Swap Disclosed
Net Loss Reported
Pricing Pressure
International Expansion
Workforce Reduction Restructuring Plan
Stock Option Grant Disclosed
Business Services
Demand Softening
Healthcare
Same Facility Growth
Other
Share Repurchase Activity Disclosed
Adjusted Ebitda Period Comparison
Quarterly Dividend Declared
Earnings Call Replay Details
Free Cash Flow Metric Disclosed
Leverage Ratio Disclosure
International Expansion
Weighted Average Interest Rate Disclosed
Ceo Earnings Call Commentary
Restructuring Charge Disclosed
Business Services
Demand Softening
Healthcare
Pricing Power Services
Same Facility Growth
Other
Executive Transition Gratitude Statement
Classified Board Director Election
Form 8K Filing Disclosure
Ceo Team Pride Statement
Earnings Call Qa Segment
Core
Management Exodus
Clinical Trial Result